Nalaganje...
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis
OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness. SETTING: UK NHS. PARTICIPANTS: Patients with...
Shranjeno v:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Group
2003
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC150460/ https://ncbi.nlm.nih.gov/pubmed/12623909 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|